Teca Partners LP Has $11.57 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Teca Partners LP increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 467,343 shares of the company’s stock after purchasing an additional 22,831 shares during the period. Acadia Healthcare accounts for 7.3% of Teca Partners LP’s portfolio, making the stock its 8th largest holding. Teca Partners LP’s holdings in Acadia Healthcare were worth $11,571,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Acadia Healthcare in the first quarter worth about $1,600,000. Goldman Sachs Group Inc. lifted its holdings in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares during the period. Envestnet Asset Management Inc. grew its holdings in Acadia Healthcare by 54.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 166,880 shares of the company’s stock valued at $3,786,000 after buying an additional 58,642 shares in the last quarter. Finally, Allworth Financial LP raised its position in shares of Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ACHC shares. KeyCorp lowered their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Barclays raised their price objective on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. Deutsche Bank Aktiengesellschaft cut their price target on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Mizuho cut their target price on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating for the company in a report on Thursday, December 18th. Finally, Guggenheim dropped their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research note on Monday, February 23rd. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $21.15.

Acadia Healthcare Trading Down 1.0%

NASDAQ:ACHC traded down $0.24 during mid-day trading on Friday, hitting $23.92. 430,375 shares of the stock traded hands, compared to its average volume of 3,897,160. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of -1.97, a PEG ratio of 8.07 and a beta of 0.74. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $31.04. The firm’s 50 day moving average is $16.61 and its two-hundred day moving average is $18.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. During the same period last year, the company earned $0.64 EPS. Acadia Healthcare’s quarterly revenue was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Appointment to board may provide governance/operational expertise — Acadia named Daniel Cancelmi to its Board of Directors, a routine governance move that can be seen as positive for oversight and strategy. Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
• Neutral Sentiment: Short-interest data reported for March appears anomalous (entries show 0 shares / NaN changes and 0.0 days-to-cover), so there’s no clear signal from short sellers on near-term positioning; treat these figures as unreliable until corrected by exchanges.
• Negative Sentiment: Zacks Research cut multiple near-term and multi-year EPS estimates and left a “Hold” rating — the firm trimmed Q2 2026 to $0.49 (from $0.66), pushed FY2026 down to $1.48 (from $1.85), and lowered FY2027 to $1.55 (from $1.96), along with reductions across several quarters. These coordinated cuts increase downside risk to sentiment and may pressure the stock as investors reprice earnings expectations.
• Negative Sentiment: Broad, repeated downward revisions across several future quarters (Q1–Q4 2026 and Q1–Q4 2027) signal potential slower-than-expected operational performance or margin pressure versus prior assumptions; combined with the company’s negative net margin and recent EPS volatility, this raises execution risk for investors.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.